Brief: Cullinan Oncology Q2 Net Income USD -42.028 Million
08/08/2024 12:00
Aug 08 (Reuters) - Cullinan Oncology Q2 operating income USD -50.027 million. * Q2 operating expenses USD 50.027 million
CGEM — Cullinan Therapeutics News Story
0.000.00%
Last trade - 00:00- $960.17m
- $625.63m